The antihyperlipidemic effects of fullerenol nanoparticles via adjusting the gut microbiota in vivo

BACKGROUND: Nanoparticles (NPs) administered orally will meet the gut microbiota, but their impacts on microbiota homeostasis and the consequent physiological relevance remain largely unknown. Here, we describe the modulatory effects and the consequent pharmacological outputs of two orally administe...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Part Fibre Toxicol
Hlavní autoři: Li, Juan, Lei, Runhong, Li, Xin, Xiong, Fengxia, Zhang, Quanyang, Zhou, Yue, Yang, Shengmei, Chang, Yanan, Chen, Kui, Gu, Weihong, Wu, Chongming, Xing, Gengmei
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2018
Témata:
Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5773151/
https://ncbi.nlm.nih.gov/pubmed/29343276
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12989-018-0241-9
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky